CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 203 enrolled
Drug / intervention
Measles vaccinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02058927
NCT02058927N/ACompleted
CompareCT.gov

Immune Reconstitution to Measles Virus of HIV-1-Infected Zambian Children Initiating Antiretroviral Therapy

University of North Carolina, Chapel Hill·observational·Posted Feb 10, 2014·Updated Sep 18, 2014

In Brief

An observational study evaluating Measles vaccine for Measles. Completed, enrolled 203 participants across 1 site.

Detailed Summary

This is an observational study of HIV-1 infected children starting antiretroviral therapy to measure the magnitude and quality of general immune reconstitution and pathogen-specific immune reconstitution to measles virus.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMeasles
CountriesZambia
CollaboratorsNational Institute of Allergy and Infectious Diseases (NIAID)

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 10, 2014
Enrollment StartMay 1, 2011
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 12.4 years ago

Interventions

Measles vaccinedrug

measles revaccination administered at 12 months from start of ART